Skip to content
Developing Drugs for Rare Diseases: Pointers and Pitfalls episode artwork

Feb 28, 2022 34 min

Developing Drugs for Rare Diseases: Pointers and Pitfalls

from LifeSci Partners Podcast Hosted by LifeSci Partners.com

There are approximately 30 million individuals in the U.S. currently living with one of at least 7,000 rare diseases. The National Organization for Rare Disorders estimates that more than 90% of these patients are still without an FDA-approved treatment. Dr. Jane Larkindale, VP of Clinical Science at PepGen, Inc. is looking to change that, and she has both the experience and passion to show you how.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Developing Drugs for Rare Diseases: Pointers and Pitfalls

0:00 34:52

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of LifeSci Partners Podcast?

This episode is 34 minutes long.

When was this LifeSci Partners Podcast episode published?

This episode was published on February 28, 2022.

Can I download this LifeSci Partners Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.